Rapport Therapeutics, Inc. (NASDAQ:RAPP) Given Consensus Rating of "Moderate Buy" by Analysts

A $19 billion portfolio manager sees a 'lost decade' for the S&P 500. Here's where he thinks investors should keep money instead.

Paraguay’s Stock Exchange Makes Its Mark At Nasdaq’s New York Headquarters

Wall Street snapped its 5-week losing streak. Here are 3 themes that caught our eye

Hiring Surged Before Oil Prices Took Off: Futures Fall

VOO costs just 0.03% a year and tracks 500 of America's largest companies. A tough market does not change that value proposition